Rocky Mountain MS Clinic and Research Group Publications and Presentations

› Poster Presentation: Overview of Survival Outcome and Functional Status in Postmarketing Cases of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Kappos L, Foley J, Gold R, Olsson T, Vermersch P, Bozic C, Cadavid D, Richert N & Richman S

5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis

Oct 19, 2011 - Oct 22, 2011, Amsterdam, The Netherlands

The objective of this study was to identify predictors of survival and describe functional status in the first 133 postmarketing natalizumab-associated PML cases. 

› Overview of clinical outcomes in cases of natalizumab-associated progressive multifocal leukoencephalopathy. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

Vermersch P, Kappos L, Gold R, Foley J, Olsson T, Bozic C, Richman S.

Sep 29, 2014 - Sep 29, 2014, Göteberg, Sweden, October 2010

› Progressive Escalation of Natalizumab Serum Concentration as a Potential Kinetic marker for PML Risk Assessment

Foley JF

Sep 29, 2014 - Sep 29, 2014, American Academy of Neurology, Honolulu, Hawaii, April 2011

› Overview of clinical outcomes in cases of natalizumab-associated progressive multifocal leukoencephalopathy

Vermersch P, Kappos L, Gold R, Foley J, Olsson T, Bozic C, Richman S.

American Academy of Neurology

Sep 29, 2014 - Sep 29, 2014, Honolulu, Hawaii, April 2011